MAP3K7 and posterior cortical atrophy: Our group has evaluated the implications of MAP3K7 and CHD1 co-loss on the AR axis and have found that PCa cells with this subtype exhibit increased AR activity, resistance to enzalutamide, and increased AR splice variant levels.